MapLight Therapeutics, Inc. Common Stock, Capital Shares Reserved for Future Issuance
MapLight Therapeutics, Inc. (MPLT) had Common Stock, Capital Shares Reserved for Future Issuance of 15.49 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-13
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 15.49M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 15.71M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 12.91M shares; Common Stock, Capital Shares Reserved for Future Issuance as first filed 12.95M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 33.84M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-06-30 | 15.49M shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 15.71M shares 10-Q · filed 2026-05-14 | |
| 2025-12-31 | 12.91M shares 10-Q · filed 2026-08-13 | 12.95M shares 10-K · filed 2026-03-26 |
| 2025-09-30 | 33.84M shares 10-Q · filed 2025-12-04 | |
| 2024-12-31 | 17.74M shares 10-K · filed 2026-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |